PL364823A1 - Kompozycje stałe, odpowiednie do podawania doustnego, zawierające nie-higroskopijne sole L-karnityny i aklanoilo-L-karnityn z chlorkiem tauryny i chlorkiem glicyny - Google Patents

Kompozycje stałe, odpowiednie do podawania doustnego, zawierające nie-higroskopijne sole L-karnityny i aklanoilo-L-karnityn z chlorkiem tauryny i chlorkiem glicyny

Info

Publication number: PL364823A1
Authority: PL; Poland
Prior art keywords: chloride; carnitine; alkanoyl; solid compositions; oral administration
Prior art date: 2000-10-31

Application number

PL01364823A

Other languages

English (en)

Other versions

PL205801B1 (pl

Inventor

Maria Ornella Tinti

Original Assignee

Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-31

Filing date

2001-09-28

Publication date

2004-12-27

2001-09-28 Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

2004-12-27 Publication of PL364823A1 publication Critical patent/PL364823A1/pl

2010-05-31 Publication of PL205801B1 publication Critical patent/PL205801B1/pl

Links

150000003839 salts Chemical class 0.000 title abstract 4
XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 title abstract 4
PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical class C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 3
-1 alkanoyl l-carnitines Chemical class 0.000 title abstract 3
239000008247 solid mixture Substances 0.000 title abstract 3
WCBVOPMSONYWEB-UHFFFAOYSA-N 2-aminoacetyl chloride Chemical compound NCC(Cl)=O WCBVOPMSONYWEB-UHFFFAOYSA-N 0.000 title abstract 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 title abstract 2
229960003080 taurine Drugs 0.000 title abstract 2
229960001518 levocarnitine Drugs 0.000 title 1
MVVVMGRRDIXCLD-UHFFFAOYSA-N 2-aminoethanesulfonyl chloride Chemical compound NCCS(Cl)(=O)=O MVVVMGRRDIXCLD-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Polymers & Plastics (AREA)
Botany (AREA)
Obesity (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Fodder In General (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

PL364823A 2000-10-31 2001-09-28 Kompozycje stałe odpowiednie do podawania doustnego, zawierające niehigroskopijne sole L-karnityny i alkanoilo-L-karnityny z chlorkiem tauryny PL205801B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2000RM000567A IT1317924B1 (it)	2000-10-31	2000-10-31	Composizioni solide atte alla somministrazione orale comprendenti salinon igroscopici della l-carnitina e delle alcanoil l-carnitine con
PCT/IT2001/000503 WO2002036543A1 (en)	2000-10-31	2001-09-28	Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride

Publications (2)

Publication Number	Publication Date
PL364823A1 true PL364823A1 (pl)	2004-12-27
PL205801B1 PL205801B1 (pl)	2010-05-31

Family

ID=11454973

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL364823A PL205801B1 (pl)	2000-10-31	2001-09-28	Kompozycje stałe odpowiednie do podawania doustnego, zawierające niehigroskopijne sole L-karnityny i alkanoilo-L-karnityny z chlorkiem tauryny

Country Status (24)

Country	Link
US (1)	US7858820B2 (pl)
EP (1)	EP1330428B1 (pl)
JP (1)	JP4181406B2 (pl)
KR (1)	KR100764155B1 (pl)
CN (1)	CN1219748C (pl)
AT (1)	ATE312810T1 (pl)
AU (2)	AU9589301A (pl)
BR (1)	BRPI0115019B1 (pl)
CA (1)	CA2427482C (pl)
CY (1)	CY1106062T1 (pl)
CZ (1)	CZ302802B6 (pl)
DE (1)	DE60115944T2 (pl)
DK (1)	DK1330428T3 (pl)
ES (1)	ES2253430T3 (pl)
HU (1)	HU229989B1 (pl)
IT (1)	IT1317924B1 (pl)
MX (1)	MXPA03003799A (pl)
NZ (1)	NZ525333A (pl)
PL (1)	PL205801B1 (pl)
RU (1)	RU2270191C2 (pl)
SI (1)	SI1330428T1 (pl)
SK (1)	SK287133B6 (pl)
WO (1)	WO2002036543A1 (pl)
ZA (1)	ZA200303328B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005031705A1 (de) *	2005-07-05	2007-01-18	Henkel Kgaa	Mittel, enthaltend L-Carnitin oder L-Carnitinderivate und mindestens eine weitere Substanz ausgewählt aus Taurin und dessen Derivaten und mindestens einem Wirkstoff, erhältlich aus Pflanzen der Gattung Echinacea
KR101007927B1 (ko)	2008-12-24	2011-01-14	주식회사 셀트리온제약	시부트라민-ｌ-카르니틴 다이술폰산염, 이의 제조방법 및 이를 포함하는 약제학적 조성물
JP5451558B2 (ja) *	2010-08-27	2014-03-26	シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ	美容活性成分の送達に有用なゲル
CN104276986B (zh) *	2013-07-12	2016-07-06	辽宁科硕营养科技有限公司	左旋肉碱牛磺酸盐的制备方法
JP6473352B2 (ja) *	2015-03-10	2019-02-20	利幸糸井	虚血性疾患治療薬
CN107325013B (zh) *	2016-04-28	2019-04-12	辽宁科硕营养科技股份有限公司	一种合成甘氨酸丙酰左旋肉碱盐酸盐的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0150688B1 (en) *	1983-12-28	1987-04-22	Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.	Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
CA2030310A1 (en) *	1989-12-22	1991-06-23	Ronald E. Macleay	Derivatives of n-hals-substituted amic acid hydrazides
IT1291126B1 (it) *	1997-04-01	1998-12-29	Sigma Tau Ind Farmaceuti	Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
IT1306147B1 (it) *	1999-05-28	2001-05-30	Biosalts Srl	Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali

2000
- 2000-10-31 IT IT2000RM000567A patent/IT1317924B1/it active
2001
- 2001-09-28 HU HU0302294A patent/HU229989B1/hu not_active IP Right Cessation
- 2001-09-28 AU AU9589301A patent/AU9589301A/xx active Pending
- 2001-09-28 DK DK01976633T patent/DK1330428T3/da active
- 2001-09-28 CZ CZ20031041A patent/CZ302802B6/cs not_active IP Right Cessation
- 2001-09-28 NZ NZ525333A patent/NZ525333A/en not_active IP Right Cessation
- 2001-09-28 SI SI200130462T patent/SI1330428T1/sl unknown
- 2001-09-28 DE DE60115944T patent/DE60115944T2/de not_active Expired - Lifetime
- 2001-09-28 MX MXPA03003799A patent/MXPA03003799A/es active IP Right Grant
- 2001-09-28 AT AT01976633T patent/ATE312810T1/de active
- 2001-09-28 CA CA2427482A patent/CA2427482C/en not_active Expired - Fee Related
- 2001-09-28 JP JP2002539304A patent/JP4181406B2/ja not_active Expired - Fee Related
- 2001-09-28 ES ES01976633T patent/ES2253430T3/es not_active Expired - Lifetime
- 2001-09-28 EP EP01976633A patent/EP1330428B1/en not_active Expired - Lifetime
- 2001-09-28 US US10/415,472 patent/US7858820B2/en not_active Expired - Lifetime
- 2001-09-28 PL PL364823A patent/PL205801B1/pl unknown
- 2001-09-28 BR BRPI0115019A patent/BRPI0115019B1/pt not_active IP Right Cessation
- 2001-09-28 CN CNB018182941A patent/CN1219748C/zh not_active Expired - Lifetime
- 2001-09-28 AU AU2001295893A patent/AU2001295893B2/en not_active Ceased
- 2001-09-28 WO PCT/IT2001/000503 patent/WO2002036543A1/en not_active Ceased
- 2001-09-28 SK SK501-2003A patent/SK287133B6/sk not_active IP Right Cessation
- 2001-09-28 RU RU2003116133/04A patent/RU2270191C2/ru active
- 2001-09-28 KR KR1020037005596A patent/KR100764155B1/ko not_active Expired - Fee Related
2003
- 2003-04-30 ZA ZA200303328A patent/ZA200303328B/en unknown
2006
- 2006-01-19 CY CY20061100074T patent/CY1106062T1/el unknown

Also Published As

Publication number	Publication date
ITRM20000567A1 (it)	2002-05-01
CA2427482C (en)	2010-04-27
EP1330428A1 (en)	2003-07-30
ES2253430T3 (es)	2006-06-01
JP4181406B2 (ja)	2008-11-12
AU9589301A (en)	2002-05-15
CN1219748C (zh)	2005-09-21
PL205801B1 (pl)	2010-05-31
HUP0302294A3 (en)	2005-05-30
CZ302802B6 (cs)	2011-11-16
NZ525333A (en)	2004-06-25
HU229989B1 (hu)	2015-04-28
ATE312810T1 (de)	2005-12-15
SK287133B6 (sk)	2010-01-07
SI1330428T1 (sl)	2006-04-30
WO2002036543A1 (en)	2002-05-10
DK1330428T3 (da)	2006-04-18
ZA200303328B (en)	2004-03-09
MXPA03003799A (es)	2004-04-20
SK5012003A3 (en)	2003-11-04
KR100764155B1 (ko)	2007-10-08
KR20030059211A (ko)	2003-07-07
BR0115019A (pt)	2003-12-23
BRPI0115019B1 (pt)	2015-10-06
HK1061230A1 (en)	2004-09-10
DE60115944T2 (de)	2006-06-29
IT1317924B1 (it)	2003-07-15
EP1330428B1 (en)	2005-12-14
DE60115944D1 (de)	2006-01-19
CZ20031041A3 (cs)	2003-08-13
US20040024061A1 (en)	2004-02-05
RU2270191C2 (ru)	2006-02-20
CY1106062T1 (el)	2011-06-08
US7858820B2 (en)	2010-12-28
CN1473144A (zh)	2004-02-04
ITRM20000567A0 (it)	2000-10-31
CA2427482A1 (en)	2002-05-10
HUP0302294A2 (hu)	2003-10-28
JP2004513107A (ja)	2004-04-30
AU2001295893B2 (en)	2006-11-30

Publication	Publication Date	Title
WO1996017587A3 (en)	1996-08-22	Oral compositions containing stabilized stannous compounds
HRP20031003A2 (en)	2004-06-30	4'-substituted nukleosides
MX9504034A (es)	1997-05-31	Formas de administracion medicamentosas que contienen acido tioctico, o sales solidas del acido tioctico de liberacion y biodisponibilidad mejoradas.
AU2001291173A1 (en)	2002-04-02	Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
BR9510168A (pt)	1997-10-14	Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
ES2183595T3 (es)	2003-03-16	Empleo de ectoina o derivados de ectoina en formulaciones.
NO20034863L (no)	2003-12-30	Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
CA2377174A1 (en)	2000-12-28	Oral administration forms for administering a fixed tramadol and diclofenac combination
BR9809368A (pt)	2000-07-04	Composições sólidas adequadas para administração oral compreendendo l-carnitina ou fumarato de magnésio de alcanoil-l-carnitina.
PT1051159E (pt)	2002-09-30	Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose
AU9589301A (en)	2002-05-15	Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride
HRP20030002A2 (en)	2005-10-31	STABLE GABAPENTIN HAVING pH WITHIN A CONTROLLED RANGE
PL367812A1 (pl)	2005-03-07	Akywne składniki alfa-ketoglutaranu i kompozycje je zawierające
BRPI9916820B8 (pt)	2023-04-25	composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método
CA2344686A1 (en)	2000-04-27	High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
IL140487A0 (en)	2002-02-10	Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines
DK1202956T3 (da)	2004-09-27	Terapeutisk og/eller ernærngsmæssigt forstærkede derivater af aktive bestanddele og oralt indgivelsesbare præparater indeholdende de samme
HUP0400737A3 (en)	2013-06-28	Use of l-carnitine for preparation of compositions for stabilizing the proteins
AU6725300A (en)	2001-04-10	Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
CO5070673A1 (es)	2001-08-28	Composiciones farmaceuticas en forma de solucion estable que comprenden (1s,4r)-cis-4-(2-amino-6-(ciclopropilamino)-9h -purin-9-il)-2-ciclopenteno-1-metanol, un quelador de metal y un agente endulzante
ES2166596T3 (es)	2002-04-16	Composiciones solidas apropiadas para administracion oral que comprende l-carnitina y tartrato de magnesio de alcanoil-l-carnitina.
ES2167878T3 (es)	2002-05-16	Composiciones solidas apropiadas para administracion oral que comprenden sales no higroscopicas de l-carnitina y alcanoil-l-carnitina con acido 2-aminoetansulfonico.
TW200505469A (en)	2005-02-16	Glycyrrhizin containing pharmaceutical composition
BR9808908A (pt)	2000-08-01	Composições sólidas adequadas para administração oral que compreendem l-carnitina ou tartarato de alcanoil-l-carnitina colina
AR008764A1 (es)	2000-02-23	Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo.